Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Journal Club

Molecular Cross Talk in Traumatic Brain Injury

Joshua D. Bell
Journal of Neuroscience 28 February 2007, 27 (9) 2153-2154; DOI: https://doi.org/10.1523/JNEUROSCI.4929-06.2007
Joshua D. Bell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Peroxynitrite (PN), a product of the near-diffusion-limited reaction between nitric oxide (NO) and mitochondrially derived superoxide (O2−), is a potent and versatile oxidant produced after brain trauma. PN can cause lipid peroxidation, DNA fragmentation, and protein nitration (Hall et al., 2004). Although the precise targets of posttranslational PN-mediated nitration and oxidation have not been fully elucidated, the activity of this radical contributes to the susceptibility of neurons to secondary injury posttrauma (Arundine and Tymianski, 2004). Recent work from Lau et al. (2006) in The Journal of Neuroscience reports novel, trauma-induced cross talk between peroxynitrite and caspases, traditional mediators of apoptotic neuronal death after traumatic brain injury (TBI) (Yakovlev et al., 1997; Clark et al., 1999, 2000). Lau et al. (2006) contend that peroxynitrite inhibits caspase-3-mediated apoptosis through cysteinyl oxidation after in vivo and in vitro neurotrauma, effectively switching the mode of cell death from apoptotic to oxidant mediated (Fig. 1).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Lau et al. (2006) suggest that cysteine oxidation of caspase-3 by peroxynitrite occurs after traumatic brain injury. The authors propose that this cross talk between reactive oxygen species and proapoptotic substrates switches the mode of cell death after trauma from apoptotic to oxidant mediated. Peroxynitrite therefore could act as a molecular switch, usurping the responsibility for progressive neurodegeneration. GK, Guanylate kinase; NMDAR, NMDA receptor; nNOS, neuronal NOS; PSD-95, postsynaptic density-95; SH3, Src homology 3.

To probe the relationship between peroxynitrite and apoptotic signaling, Lau et al. (2006) used an in vitro neuronal stretch model of TBI. The authors observed apoptotic-like cell death (characterized by terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling staining and DNA laddering similar to that observed with staurosporine) in neurons exposed to NMDA and sublethal neuronal stretch [Lau et al. (2006), their Fig. 1B,C (http://www.jneurosci.org/cgi/content/full/26/45/11540/F1)]. Although the cells demonstrated cytochrome c translocation and PN formation [Lau et al. (2006), their Fig. 2A,D (http://www.jneurosci.org/cgi/content/full/26/45/11540/F2)], they lacked activated caspase-3, a traditional feature of apoptotic neurons [Lau et al. (2006), their Fig. 2B,C (http://www.jneurosci.org/cgi/content/full/26/45/11540/F2)]. Lau et al. (2006) hypothesized that PN directly inhibited apoptosis in addition to causing the observed DNA fragmentation in mechanically injured cells. The authors believed that this might underlie their observation of cytochrome c release in the absence of caspase-3 activation.

Lau et al. (2006) asked whether PN directly inhibited caspase-3 or whether it interfered with the steps between cytochrome c release and subsequent activation of caspase-3. Using an antibody to 3-nitrotyrosine, the authors immunoprecipitated the inactive form of caspase-3 (procaspase; a 32 kDa band) after trauma [Lau et al. (2006), their Fig. 3 (http://www.jneurosci.org/cgi/content/full/26/45/11540/F3)]. In an ex vivo system, Lau et al. (2006) also observed direct inhibition of fluorogenic caspase-3 activity by the PN donor 3-morpholinosydnonimine (SIN-1) and a complete block by PN itself [Lau et al. (2006), their Fig. 4A (http://www.jneurosci.org/cgi/content/full/26/45/11540/F4)]. Additional exposure of caspase-3 to PN in the presence of a sulfhydryl-reducing agent [dithiothreitol (DTT)] reduced the inhibition of caspase-3 activity by PN, indicating that an oxidative modification of cysteine residues, rather than tyrosine nitration, was primarily responsible for inhibition of caspase-3 [Lau et al. (2006), their Fig. 4B (http://www.jneurosci.org/cgi/content/full/26/45/11540/F4)].

Could a PN donor inhibit caspase-3 activation in neurons destined to die from apoptosis? Using SIN-1, Lau et al. (2006) demonstrated robust inhibition of staurosporine-induced fluorogenic caspase-3 activity and immunoreactivity, as well as the attenuation of traditional downstream apoptotic activity such as PARP-1 [poly-(ADP-ribose) polymerase-1] cleavage and phosphatidylserine inversion [Lau et al. (2006), their Fig. 7 (http://www.jneurosci.org/cgi/content/full/26/45/11540/F7)]. Cell death, however, was not inhibited. The authors thus concluded that cellular demise could be effectively shifted to a caspase-independent pathway through exposure to PN.

To examine the applicability of these findings to an in vivo model of cortical trauma, the authors used the lateral fluid percussion injury model. TBI induced robust 3-NT (3-nitrotyrosine) immunoreactivity in injured rat cortex [Lau et al. (2006), their Fig. 8B,E (http://www.jneurosci.org/cgi/content/full/26/45/11540/F8)] in the absence of activated caspase-3 [Lau et al. (2006), their Fig. 8F (http://www.jneurosci.org/cgi/content/full/26/45/11540/F8)]. When lysates from injured cortex, but not uninjured cortex, were incubated with DTT, fluorogenic caspase-3 activity markedly increased [Lau et al. (2006), their Fig. 10A (http://www.jneurosci.org/cgi/content/full/26/45/11540/F10)]. Thus, substantial caspase-3 existed in an inhibited, oxidized state as a direct result of the injury. Given that this could be reversed by DTT incubation, the authors concluded that the observed caspase-3 inhibition was a result of PN-induced cysteinyl oxidation.

Lau et al. (2006) describe a multifaceted role for trauma-induced PN formation. In addition to inhibiting classical apoptosis, PN still can play a lethal role in posttrauma neuropathology. PN inhibition may disinhibit proapoptotic substrates and thus underlie the variable cytoprotective efficacy of reactive oxygen species scavengers after brain trauma (Lewen et al., 2001; Marklund et al., 2001). The authors therefore suggest that combined anti-oxidant and anti-apoptotic strategies may be necessary in post-TBI treatment. In light of the evidence presented by Lau et al. (2006), what can we learn about controlling the activity of peroxynitrite and using it advantageously? Specifically, can PN-dependent cysteine oxidation of caspase-3 be preserved while reducing the damage inflicted by this radical?

The source specificity of PN formation might be important in harnessing the caspase-inhibiting activity of PN and using it appropriately. After brain injury, inducible nitric oxide synthase (NOS), endothelial NOS, and neuronal NOS all underlie PN formation (Wada et al., 1998, Gahm et al., 2005). However, we do not know that the radicals produced by all of these sources have identical downstream effects (e.g., caspase inhibition vs DNA fragmentation). Do the heterogeneous activities of PN identified by these authors come about because of the different cellular locations of production of the radicals? The endogenous source of NO responsible for this molecular switch is still unidentified, and the effects of inhibiting various combinations of NO sources on specific PN activities have not been mapped out. However, the interplay among NO synthases, PN levels, caspase activity, and radical-induced cell damage after traumatic brain injury can now be further investigated.

Footnotes

  • Editor's Note: These short reviews of a recent paper in the Journal, written exclusively by graduate students or postdoctoral fellows, are intended to mimic the journal clubs that exist in your own departments or institutions. For more information on the format and purpose of the Journal Club, please see http://www.jneurosci.org/misc/ifa_features.shtml.

  • Correspondence should be addressed to Joshua D. Bell at the above address. bellj{at}smh.toronto.on.ca

References

  1. ↵
    1. Arundine M,
    2. Tymianski M
    (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61:657–668.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Clark RS,
    2. Kochanek PM,
    3. Chen M,
    4. Watkins SC,
    5. Marion DW,
    6. Chen J,
    7. Hamilton RL,
    8. Loeffert JE,
    9. Graham SH
    (1999) Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 13:813–821.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Clark RS,
    2. Kochanek PM,
    3. Watkins SC,
    4. Chen M,
    5. Dixon CE,
    6. Seidberg NA,
    7. Melick J,
    8. Loeffert JE,
    9. Nathaniel PD,
    10. Jin KL,
    11. Graham SH
    (2000) Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem 74:740–753.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Gahm C,
    2. Danilov A,
    3. Holmin S,
    4. Wiklund PN,
    5. Brundin L,
    6. Mathiesen T
    (2005) Reduced neuronal injury after treatment with NG-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) following experimental brain contusion. Neurosurgery 57:1272–1281.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Hall ED,
    2. Detloff MR,
    3. Johnson K,
    4. Kupina NC
    (2004) Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma 21:9–20.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Lau A,
    2. Arundine M,
    3. Sun HS,
    4. Jones M,
    5. Tymianski M
    (2006) Inhibition of caspase-mediated apoptosis by peroxynitrite in traumatic brain injury. J Neurosci 26:11540–11553.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Lewen A,
    2. Skoglosa Y,
    3. Clausen F,
    4. Marklund N,
    5. Chan PH,
    6. Lindholm D,
    7. Hillered L
    (2001) Paradoxical increase in neuronal DNA fragmentation after neuroprotective free radical scavenger treatment in experimental traumatic brain injury. J Cereb Blood Flow Metab 21:344–350.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Marklund N,
    2. Clausen F,
    3. McIntosh TK,
    4. Hillered L
    (2001) Free radical scavenger posttreatment improves functional and morphological outcome after fluid percussion injury in the rat. J Neurotrauma 18:821–832.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Wada K,
    2. Chatzipanteli K,
    3. Kraydieh S,
    4. Busto R,
    5. Dietrich WD
    (1998) Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 43:1427–1436.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Yakovlev AG,
    2. Knoblach SM,
    3. Fan L,
    4. Fox GB,
    5. Goodnight R,
    6. Faden AI
    (1997) Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 17:7415–7424.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

The Journal of Neuroscience: 27 (9)
Journal of Neuroscience
Vol. 27, Issue 9
28 Feb 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Cross Talk in Traumatic Brain Injury
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Molecular Cross Talk in Traumatic Brain Injury
Joshua D. Bell
Journal of Neuroscience 28 February 2007, 27 (9) 2153-2154; DOI: 10.1523/JNEUROSCI.4929-06.2007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Molecular Cross Talk in Traumatic Brain Injury
Joshua D. Bell
Journal of Neuroscience 28 February 2007, 27 (9) 2153-2154; DOI: 10.1523/JNEUROSCI.4929-06.2007
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Adult-Born Granule Cells Contribute to Dentate Gyrus Circuit Reorganization after Traumatic Brain Injury
  • The Oscillatory Nature of Movement Initiation
  • Lateral Preoptic Hypothalamus: A Window to Understanding Insomnia
Show more Journal Club
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.